[3] [19] While the mean half-life of Zepbound is approximately 5 days, several patient-specific factors may influence individual pharmacokinetics, though the clinical significance of these variations is generally limited
Martnez-Salgado C, Fuentes-Calvo I, Garca-Cenador B, Santos E, Lpez-Novoa JM
The metabolic effects of testosterone extend far beyond what most people realize
This leads to a very pertinent and widely discussed question whether the management of diabetes should be more adipose-centric, or whether obesity management should be a primary treatment target for patients with T2D [6]
Robert Kushner, a co-author of the study and a professor at Northwestern
The relation between TMAO and chronic disease can be ambiguous, involving kidney function [79], disturbed gut-blood barrier [83], or flavin-containing monooxygenase 3 genotype [84]